IDAMS
"International Research Consortium on Dengue Risk Assessment, Management, and Surveillance"
| Coordinatore | UNIVERSITAETSKLINIKUM HEIDELBERG
Organization address
address: IM NEUENHEIMER FELD 672 contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Totale costo | 7˙698˙584 € |
| EC contributo | 5˙999˙213 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2011-single-stage |
| Funding Scheme | CP-FP-SICA |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-09-01 - 2016-08-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITAETSKLINIKUM HEIDELBERG
Organization address
address: IM NEUENHEIMER FELD 672 contact info |
DE (HEIDELBERG) | coordinator | 948˙038.20 |
| 2 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 2˙189˙161.50 |
| 3 |
WORLD HEALTH ORGANIZATION.
Organization address
address: Avenue Appia 20 contact info |
CH (GENEVE) | participant | 1˙101˙300.00 |
| 4 |
LIVERPOOL SCHOOL OF TROPICAL MEDICINE
Organization address
address: Pembroke Place contact info |
UK (LIVERPOOL) | participant | 348˙167.75 |
| 5 |
FONDAZIONE PER L'ISTITUTO DI RICERC A IN BIOMEDICINA
Organization address
address: Via Vincenzo Vela 6 contact info |
CH (BELLINZONA) | participant | 289˙920.00 |
| 6 |
ENVIRONMENTAL RESEARCH GROUP OXFORD LIMITED
Organization address
address: Ryelands Grove 10 contact info |
UK (LEOMINSTER) | participant | 148˙762.80 |
| 7 |
FRIENDS WITHOUT A BORDER
Organization address
address: 1123 Broadway 1210 contact info |
US (NEW YORK) | participant | 133˙980.00 |
| 8 |
UNIVERSITY OF MALAYA
Organization address
address: LEMBAH PANTAI contact info |
MY (KUALA LUMPUR) | participant | 125˙100.00 |
| 9 |
MINISTERIO DE SALUD PUBLICA Y ASISTENCIA SOCIAL
Organization address
address: CALLE ARCE 827 contact info |
SV (SAN SALVADOR) | participant | 121˙445.00 |
| 10 |
INSTITUTO DE MEDICINA TROPICAL PEDRO KOURI
Organization address
address: AUTOPISTA NOVIA MEDIODIA KM 6 1/2 contact info |
CU (LA HABANA) | participant | 111˙420.00 |
| 11 |
FUNDACAO OSWALDO CRUZ
Organization address
address: AVENIDA BRASIL 4365 contact info |
BR (RIO DE JANEIRO) | participant | 101˙760.00 |
| 12 |
GADJAH MADA UNIVERSITY
Organization address
address: BULAKSUMUR contact info |
ID (YOGYAKARTA) | participant | 65˙835.00 |
| 13 |
INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH BANGLADESH
Organization address
address: SHAHEED TAJUDDIN AHMED SHARANI 68 contact info |
BD (DHAKA) | participant | 57˙960.00 |
| 14 |
INDEPTH NETWORK
Organization address
address: "Mensah Wood Street, East Legon 11" contact info |
GH (ACCRA) | participant | 55˙800.00 |
| 15 |
STICHTING INTERNATIONAL RED CROSS RED CRESCENT CENTRE ON CLIMATE CHANGE AND DISASTER PREPAREDNESS
Organization address
address: LEEGHWATERPLEIN 27 contact info |
NL (DEN HAAG) | participant | 54˙000.00 |
| 16 |
UNIVERSIDAD AUTONOMA DE YUCATAN
Organization address
address: CALLE 60 491A 57 COL CENTRO contact info |
MX (MERIDA YUCATAN) | participant | 53˙922.64 |
| 17 |
FUNDACAO UNIVERSIDADE ESTADUAL DO CEARA
Organization address
address: AV PARANJANA 1700 contact info |
BR (FORTALEZA) | participant | 48˙480.00 |
| 18 |
UNIVERSIDAD DE CARABOBO
Organization address
address: Avenida Bolivar Norte contact info |
VE (Valencia) | participant | 44˙160.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The overall concept of this research project is to assemble a consortium of international experts working together to develop new and innovative tools to be applied to the control of dengue in a global context. The core of the application focuses on parallel strategies aimed at:
• improving diagnosis and clinical management of dengue through two linked work packages designed a) to identify readily available clinical and laboratory parameters and/or viral and immunological markers, that differentiate between dengue and other common febrile illness within 3 days of fever onset, and b) to identify any of the available markers that are predictive of the likelihood of evolving to a more severe disease course
• assessing the risk of dengue spread though linked work packages focused on a) mapping and modelling techniques to define the current extent of dengue disease globally and to evaluate possible scenarios of spread or risk to previously uninfected regions in the future, and b) developing effective and affordable early warning and outbreak response systems.
These four work packages are supported by a fifth work package dedicated to networking and translational activities to ensure that outputs from the various research activities are used to maximal advantage.'
Introduzione (Teaser)
Around 400 million cases of dengue fever worldwide highlight the need for better disease management as well as effective transmission control and therapy. EU funding is supporting scientists in this endeavour.
Descrizione progetto (Article)
Following a recent pandemic of dengue fever in Madeira, the World Health Organisation raised an alert regarding disease incidence and outbreak frequency. Indeed the global distribution of the disease has reached unprecedented levels with more countries reporting dengue fever cases.
Currently, there are no therapies or vaccines available and clinical management of the disease mainly entails careful monitoring and use of intravenous fluid therapy. The activities of the EU-funded 'International research consortium on dengue risk assessment, management, and surveillance' (http://www.idams.eu/ (IDAMS)) project will address the need for new diagnostic and clinical tools for dengue fever management.
The consortium will rely on clinical and laboratory parameters as well as viral and immunological biomarkers to differentiate between dengue and other common illnesses. IDAMS will also concentrate on mapping dengue disease globally and evaluating possible scenarios of spread to other regions in the future. Equally important is the development of effective and affordable early warning and outbreak response systems.
IDAMS is studying patients with dengue fever to identify clinically useful correlates of severe dengue along with markers that detect disease evolution to severe forms. Innovative diagnostic tools are currently being developed to enhance the efficacy, sensitivity and speed of dengue fever detection. Active research into an effective vaccine is also underway and one of the project milestones is to delineate the mechanisms of protective immunity.
Considerable efforts have gone into outbreak prediction. IDAMS members reviewed current practices in dengue surveillance systems and their impact on dengue control. By combining epidemiological data from different countries they generated a disease prediction model. Based on this model, the major risk factors seem to be the temperature, the presence of dengue cases and the age of dengue-infected individuals.
Alongside vector distribution maps, climatic and socioeconomic data, this information will provide estimates on the global distribution of dengue fever up to the year 2080. Such data should also help in developing better tools, policies and guidelines to prevent or contain dengue transmission.